Nucleus, a whole-genome testing startup, is talking with its investors and other capital partners to possibly buy assets from now-bankrupt 23andMe, CEO Kian Sadeghi tells Axios exclusively.
Why it matters: Nucleus is the only buyer to vocally express interest besides 23andMe co-founder and former CEO Anne Wojcicki.
